---  
layout: startup_page  
title: "Ottimo Pharma"  
id: "ottimopharma.com"  
permalink: "/ottimopharmaottimopharma.com12192024/"  
website: "https://ottimopharma.com/"  
funding_round: "Series A"  
funding_amount: "$140M"  
investors: "OrbiMed, Avoro Capital, Samsara BioCapital, RTW Investments, Decheng Capital, Janus Henderson Investors, J.P. Morgan Life Sciences Private Capital, Invus, Medicxi"  
about: "Ottimo Pharma is a private biotech company developing bifunctional medicines for cancer treatment. Their lead asset, Jankistomig, is a first-in-class PD1/VEGFR2 bifunctional antibody targeting immune checkpoint inhibition and angiogenesis. This innovative approach aims to improve outcomes across multiple solid tumor indications."  
markets: "Biotechnology, Oncology, Health Care, Pharmaceutical"  
hq: "Sandwich, Kent, United Kingdom"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/ottimo-pharma"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/ottimo-pharma"  
pitchbook: "https://pitchbook.com/profiles/company/706251-97"  

date_display: "19-Dec-2024"  
date: "2024-12-19"

# SEO Optimization  
meta_title: "Ottimo Pharma - Series A Funding ($140M)"  
meta_description: "Ottimo Pharma, Ottimo Pharma is a private biotech company developing bifunctional medicines for cancer treatment. Their lead asset, Jankistomig, is a first-in-class ..."  
meta_keywords: "Ottimo Pharma, Biotechnology, Oncology, Health Care, Pharmaceutical, Series A funding"  
canonical_url: "https://startup.projectstartups.com/ottimopharmaottimopharma.com12192024/"  
---